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Background: Limited study on the use of complementary alternative medicine (CAM) among patients with diabetes
mellitus (DM), particularly in primary -care settings. This study seeks to understand the prevalence, types, expenditures,
attitudes, beliefs, and perceptions of CAM use among patients with DM visiting outpatient primary care clinics.
Methods: This is a descriptive, cross-sectional study of 240 diabetic patients. CAM is defined as a group of diverse medical
and healthcare systems, practices, and products that are not generally considered part of conventional Western medicine.
Data analysis was done using SPSS v. 19 and multiple logistic regressions were used to identify predictors of CAM use.
Results: The prevalence of CAM use was 62.5 percent. Female were 1.8 times more likely than male in using CAM. Malays
(75%) were the most frequent users, followed Indians (18%) and Chinese (6%). Biological therapy (50.0%) were the most
widely used, followed by manipulative-body based systems (9.2%), energy system (8.8%), alternative medicine systems
(4.6%) and mind-body system (1.7%). In biological therapy, a total of 30.4 percent, 24.2 percent, 13.3 percent, and 7.9
percent of diabetic patients consumed bitter gourd (Momordica Charantia), followed by Misai Kucing (Orthosiphon
Stamineus Benth), garlic (Allium Sativum), and Sabah snake grass (Clinacanthus Nutans Lindau) respectively. The mean of
the expenditure on CAM usage was RM 52.8 ± 101.9 (US $16.9 ± 32.5) per month. According to multiple logistic
regression analyses, being Muslim (OR 5.258, 95 percent CI 2.952-9.368) had significant positive association with CAM use.
Conclusions: The prevalence of CAM use was high among diabetics. Islam faith is predictor for CAM use among Type 2
DM patients. The most-common herbs used were bitter gourd (Momordica Charantia) and Misai Kucing (Orthosiphon
Stamineus, Benth). Further studies on the anti-glycemic activity of the isolated compound may be needed in the future.
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Complementary and alternative medicine (CAM) is de-
fined as a group of diverse medical and healthcare sys-
tems, practices, and products that are not generally
considered part of conventional Western medicine [1,2].
CAM use can be divided into five categories: biological-
based therapies like herbal and dietary supplement; al-
ternative medical systems like acupuncture or Ayurveda;
energy therapies like Reiki; manipulative and body-based* Correspondence: siewmooi@medic.upm.edu.my
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reproduction in any medium, provided the orsystems like chiropractic or massage; and mind-body in-
terventions like tai chi or yoga [3].
CAM usage is common among patients with diabetes
mellitus (DM). A better understanding of CAM use will
help the medical profession be more vigilant and patient-
centered, particularly during counseling sessions regarding
proper use herbal remedies in the stream of modern
medicine.
The prevalence of CAM usage among DM patients has
a wide range (17–72.8 percent) due to different definitions
in the studies [4]. Studies show that white middle-aged,
being women, receiving higher education and those suffer
from more than one chronic disease (especially metabolic,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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correlation with the use of CAM [5,6].
Studies reported that herbal remedies, vitamins,
spirituality, and exercise are common CAM therapies
pursued by diabetics [4]. Among the herbal remedies,
true cinnamon (Cinnamomum verum) is used com-
monly in the United States and Canada [7]. Bitter
gourd (Momordica Charantia) and garlic (Allium
Sativum) are predominantly used in India [8]. In Asia and
Mediterranean, fenugreek (Trigonella Foenum Graecum)
has been cultivated and used medicinally for thousands
of years [9,10]. In Malaysia, there are 12,000 plants. How-
ever, only about 1,300 herbs have been found to have
therapeutic benefits [11]. This indicates that local herbs
were underutilized, as not much study has been done
on useful local herbs in treating or controlling diabetes
[12]. Studies actually show that CAM remedies can be an
important component of health self-management, de-
pending on the patient’s financial resources, culture, and
self-empowerment [13,14]. Therefore, this study was
conducted to examine the prevalence, types, reasons, and
expenditures devoted to CAM among DM patients at-
tending an outpatient primary-care clinic in Malaysia.
Methods
Setting
This is a cross-sectional study of patients registered
with the primary health care clinic at Salak in Sepang,
Selangor, Malaysia. This clinic is run by a family medicine
specialist and 10 medical officers.
Inclusion criteria
All registered diabetics more than age 18 and above
and a minimum follow-up of three months at Klinik
Kesihatan Salak, Sepang, were eligible for the study. The
sample size was calculated by using Epi Info 6.0, based
on the prevalence in local studies, which ranged from
50–56 percent [15,16]. The estimated sample size was
185 with 90 percent power, 95 percent confidence inter-
val (CI), and statistical significant level (α) at 5 percent.
The total number of respondents needed was 240, after
taking into account a non-respondent rate of 30 percent.
Patients were selected using a random sampling method.
The estimated number of diabetic patients that visit the
clinic per day and in three weeks’ time were 32 patients
and 480 patients. Since the number of required test subjects
was 240, the sampling interval of two was used as the con-
stant difference between subjects. The first starting number
of 2 was picked randomly from the registration counter.
Data collection
A face-to-face interview was conducted using a struc-
tured questionnaire. A written informed consent for par-
ticipation in the study was obtained from participants.The questionnaire was designed to capture patients’
socio-demographic data, co-morbidities, types of CAM
used, resources consulted, and the total expenditure on
CAM. The attitudes, beliefs, and perceptions towards
CAM were explored. Documented most-recent results
of glycosylated hemoglobin (HbA1C) and blood pressure
(BP) tests from the preceding year were captured from
the patients’ medical records. A pilot study involving 42
patients was done to pretest the questionnaire and esti-
mate the likely response rate. The main survey was ad-
ministered during the first three weeks of May 2011 by
three medical students.
Practical definition
A DM patient was defined as someone who was clinic-
ally diagnosed with diabetes or was taking diabetic medi-
cations. Patients with hypertension were those whose
BP ≥ 140/90 mmHg or were on antihypertensive agents.
CAM use in this study is defined as consumption in
one of the five categories therapy: biological-based ther-
apies like herbal and dietary supplement; alternative
medical systems, like acupuncture or Ayurveda; energy
therapies like Reiki; manipulative and body-based sys-
tems like chiropractic or massage; and mind-body inter-
ventions like tai chi or yoga [3].
Data analysis
Statistical Package for Social Sciences (SPSS) v. 19.0 was
used to analyze the data collected from the study. The
findings were described in terms of frequencies, percent-
ages, means, and standard deviations. The association
between socio-demographic factors (gender, age, race,
religion, educational, occupation, family household in-
come, and duration and control of diabetes) and the
CAM usage was determined by using Chi-square test.
Multivariate logistic regressions were used to identify
predictors of CAM usage.
Ethical approval
Ethical approval was obtained from the Ethics Commit-




A total of 252 subjects was eligible in the original co-
hort; 12 of them refused to participate in the study. In
the end, 240 diabetic patients were enrolled into the
study with the response rate of 95 percent. Table 1 shows
the socio-demographic information of respondents. The re-
spondents were predominantly female Malayan Muslims
50–69 years old with a mean age of 55.14 ± 10 years. Most
received primary education and the average monthly house-
hold income was RM 1843.17 ± 1537 (USD 588). The mean
Table 1 Demographic and clinical characteristics of the
diabetic respondents in Klinik Kesihatan Salak (N=240)






Female 145(60.4) 96 (64.0)
Race
Malays 145 (60.4) 112 (74.7)
Chinese 14(5.8) 9 (6.0)
Indians 79(32.9) 27 (18.0)
Religion
Muslim 150(62.5) 116 (77.3)
Buddhist 13(5.4) 8 (5.4)
Hindu 71(29.6) 24 (16.0)
Christian 6(2.5) 2 (1.3)
Level of Education
No education 31(12.9) 18 (12.0)
Primary 99(41.2) 57 (38.0)
Secondary 94(39.2) 64 (42.7)
Tertiary 16(6.7) 11 (7.3)
Occupation
Blue collar 101(42.1) 52 (34.7)
White collar 139(57.9) 98 (65.3)
Family Household Income
0 – 2500 189(78.8) 116 (77.3)
2501 – 5000 44(18.3) 29 (19.3)
5001 – 7500 3(1.2) 1 (0.4)
7501–10000 4(1.7) 4 (1.7)
Table 2 Type of CAM used by DM patients in Klinik
Kesihatan Salak (N=150)




Bitter gourd 73 48.7
Misai Kuching 58 38.7
Garlic 32 21.3
Sabah snake grass 19 12.7
Basil leaf 5 3.3
Ginseng 4 2.7
Manipulative and body-based systems 22 14.7
Reflexology 22 14.7
Alternative medical systems 11 7.3
Ayurveda 10 6.7
Acupuncture 3 2.0
Energy therapies 21 14.0
Reiki 3 2.0
Massage bed 18 12.0
Mind-body interventions 4 2.7
Yoga/tai chi 4 2.7
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years and 8.7 ± 2.8 percent respectively. Most respondents
(72.9 percent) had underlying hypertension followed by
dyslipidemia (11.3 percent), asthma (1.7 percent), and
osteoarthritis (0.8 percent). The mean systolic and diastolic
blood pressures were 138 ± 19 and 82 ± 12 mmHg,
respectively.
Types of CAM used by DM patients
The prevalence of CAM use was 62.5 percent. Female were
1.8 times more likely than male. Malays (75%) were the
most frequent users, followed Indians (18%) and Chinese
(6%). Table 2 shows CAM use among DM patients. Bio-
logical therapy which involved the herbal products (50.0%)
were the most widely used, followed by manipulative-body
based systems (9.2%), energy system (8.8%), alternative
medicine systems (4.6%) and mind-body system (1.7%). Bit-
ter gourd (30.4 percent, n=73) was the most popular nat-
ural product consumed by respondents. Other commonly
used herbal products included Misai Kuching (24.2 percent,n=58) and garlic (13.3 percent, n=32). Surprisingly, none of
them sought help from a religion master and/or “bomoh.”Attitudes, beliefs, and perceptions toward CAM
More than half of survey respondents pursued CAM
therapies because they believed CAM can help them
achieve better control in diabetes (58.0 percent) and bet-
ter value for money (17.3 percent). Some use it because
they are following the example of other CAM users
(17.3 percent) (Table 3).Resources on CAM
This study found that most respondents learned about
CAM primarily from friends (32.1 percent) and family
(13.8 percent) followed by media (13.3 percent) and
health professionals. The mean duration of CAM usage
was 4.0 ± 4.6 years. The mean frequency of consumption
was 3.5 times per week.Expenditures on CAM
The mean of the total out-of-pocket expenditure on
CAM usage was RM 52.8 ± 101.9 (US $16.9 ± 32.5) per
month. The vast majority (87.5 percent) of respondents
spent RM 52.8 (US$16.9) or less per month on CAM.
Thirty patients (12.5 percent) spent more than RM 52.8
(US$16.9) per month on CAM therapies.
Table 3 Attitudes, beliefs, and perceptions questionnaires
toward CAM (N=150)
Attitudes, beliefs and perceptions towards
complementary alternative medicine
n %
Believe CAM can help the diabetes control 87 58.0
Having good example from the other user
of CAM and keen to share with others
26 17.3
Easily available and better value for money 26 17.3
Dissatisfied with western medicines 5 3.3
Use for other co morbidity treatment 5 3.3
Believed that CAM had fewer side effects 1 0.7
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Table 4 summarizes the characteristic differences be-
tween CAM users and non-CAM users. The results of
unadjusted univariate logistic regression analysis of vari-
ables related to CAM users were calculated. A multivari-
ate logistic regression analysis was used to independently
predict a CAM user after adjustment for variables that
attained P < 0.05 in univariate analysis and clinicalTable 4 Association of characteristics between patients
who used CAM and those who did not use CAM (N=240)
Socio-demographic factors No CAM use CAM use
n=90, (%) n=150, (%) p-value
Gender
Male 41 (45.6) 54 (36.0) 0.163
Female 49 (54.4) 96 (64.0)
Ethnicity
Malays 33(36.7) 112 (74.7) <0.001
Chinese 5 (5.6) 9 (6.0)
Indians 52 (57.8) 27 (18)
Religion
Islam 34(37.8) 116 (77.3) <0.001
Buddhist 5 (5.6) 8 (5.3)
Hindu 47 (52.2) 24 (16.0)
Christian 4 (4.4) 2 (1.3)
Education
Primary school and below 55 (61.1) 75(50.0) 0.115
Secondary school and above 35 (38.9) 75 (50.0)
Occupation
Blue collar 48(53.3) 52 (34.7) 0.005
Non Blue collar 42 (46.7) 98 (65.3)
Hypertension 63 (70.0) 112 (74.7) 0.431
Family Household Income (n, SD) 1536±1236 2030±1666 0.019
HbA1c (n, SD) 8.5±1.7 8.9±3.0 0.448
There is significant association if p-value <0.05 *.
CAM: complementary alternative medicine.
SD: standard deviation.
n=number.significant variables. Being Muslim (odds ratio [OR] 5.258,
95 percent, CI 2.952-9.368) is the only predictor for CAM
use after adjustments for gender, ethnicity, religion, occu-
pation, family household income and hypertension.
Discussion
The prevalence of CAM usage among DM patients in
this study population was high (62.5 percent). This is
consistent with findings in other studies [4]. The current
usage is higher than studies in the United Kingdom (17
percent) [17], Australia (23.6 percent) [18], Turkey (41.0
percent) [19], and Thailand (47 percent) [20]. This is
comparable to studies in Taiwan (61 percent) [21] and
Mexico (62 percent) [22] and lower compared to Korea
(65 percent) [23], India (67.7 percent) [24], and the U.S.
(72.8 percent) [25]. Our results were much higher com-
pared to the local population study, where only 2.3 per-
cent of Malaysians consumed CAM overall [26] and 0.2
percent of DM patients had experience in using CAM
[27]. However, this may be underreported as other stud-
ies mention that patients with chronic diseases like dia-
betes tend to consume CAM compared to the general
population [4,7,25,28,29]. Our result is still higher when
compared to the two other local studies done at the Ipoh
primary care clinic (56 percent) and Seremban Govern-
ment Hospital diabetes health clinic (49.6 percent) re-
spectively [15,16].
Previous studies reported that the reasons for DM
patients to choose such therapies may be related to the
fact that diabetes is a chronic, devastating, and incurable
disease. Patients may have positive views of CAM due to
its organic nature (which can present fewer side-effects),
concerns about doctors’ listening skills, preferences to
be treated holistically, and increased availability of CAM
[10,30].
In the present study, only a small portion of patients
were dissatisfied with conventional medicines (3.3 per-
cent) and believed that traditional medicine presented
more adverse effects (0.7 percent). This was surprising,
since previous studies had shown dissatisfaction with
conventional treatments due to ineffectiveness or un-
pleasant side effects were the common reasons for pur-
suing CAM. This is consistent with a US-based study
that reported “users of alternative health care are no
more dissatisfied with or distrustful of the conventional
care than nonusers are” [10]. One possible reason for
our findings is a change in society that links to a patient
self-empowerment paradigm [31]. Most DM patients
had poor blood-sugar control, as the conventional treat-
ment requires them to be disciplined with respect to
diet, lifestyle, and behavior [32,33]. Because of this, pa-
tients tend to try CAM to optimize their health status so
that they feel that they have partially contributed to the
management of their disease. They believe CAM offers
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[34-36]. On the other hand, it could be related to under-
lying shared beliefs and cultural assumptions [37].
In our study, the main types of CAM used were herbal
and dietary supplements as well as reflexology. The high
consumption is not surprising, since most diabetics pre-
sumed that herbs are safer and, additionally, more af-
fordable and easily available [16,38,39]. This was further
supported by the fact that the total out-of-pocket ex-
penditure was RM 52.8 ± 101.9 (US $17.0 ± USD32.8)
per month. The most common sources of CAM infor-
mation were recommendation from friends and families.
The present study indicates that we must involve pa-
tients’ friends and the families during diabetes education
counseling regarding the efficacy and potential side-
effects of CAM.
Malaysia is a multiethnic, multicultural, multi-religious
developing nation in which Malays form the majority,
constituting 50.4 percent of the population [40]. CAM
use is deeply rooted and influenced by its multicultural
and religious nature. It has had ethnic diversity and this
influences CAM use as well. Uses of herbs [41] like bit-
ter gourd [42-44], Misai Kucing (Orthosiphon Stamineus
Benth) [45,46], garlic (Allium Sativum) [47,48], and gin-
seng (Panax Ginseng) [49] are believed to reduce blood
sugar levels. Bitter gourd [50], also known as Momordica
Charantia is a tropical vine that is widely believed to
bring down blood sugar levels, despite a lack of robust
evidence [43,44,50-52]. Bitter gourd was widely used as
ayuverda treatment in India. It was found to be the most
common herb used as before 15th century and trad-
itional Malay medicine has been strongly influenced by
the animistic culture of Hindu-Buddhism, thus the use
of the bitter gourd is already deeply ingrained in the
Malay population [26].
Interestingly, Sabah snake grass (Clinacanthus Nutans
Lindau), an anti-inflammatory used for treating insect
bites and herpes infections in Thailand [53], has also
been widely used by DM patients. The users believe it
contains anti-glycemic components. This may merit fur-
ther study.
Belief in Islam was found to be one of the strongest
predictors for pursuing CAM therapy. One explanation
for this may be that CAM usage has always been embed-
ded into the Muslim belief system and cultural heritage
that is already deeply integrated into their lives [54,55].
Indeed, Malaysia is unique in its role as a confluence of
three Asian cultures, giving rise to three main traditional
healing practitioners. However, Malaysia is an Islamic
country, so this may explain why only a belief in the
Muslim religion is a predictor of CAM usage.
Older female patients with higher levels of education
and household income were more likely to be CAM
users in some studies [56-58]. However, the presentstudy found no significant relationship in CAM usage
and gender, mean age, ethnic group, education level, or
total household income. This could be because the stud-
ied population was DM patients, who might be more
likely to resort to CAM therapies - regardless of gender
or socio-demographic status. This is supported by a U.S.-
based study that reported that DM patients were 1.6 times
more likely to use CAM than non-diabetics [58]. The
HbA1C also was not found to have relationship as the
control of diabetes was confounded by other factors such
as compliance as well as other treatment modalities. This
is important because, although there is increasing global
interest in CAM use worldwide, doctors who practice
Western medicine seem less aware about its significance
and importance. By right, as health-care professionals, we
should be knowledgeable about potential benefits and
possible toxicities of such remedies [59]. Practitioners
should provide evidence-based information on safety is-
sues, efficacy, and potential interactions among commonly
used CAM treatments – instead of brushing the topic
aside or ignoring its usage.Strength and limitations
This will be interesting to include non-diabetic group as
the control group in this study. However, it was not
done due to the time constraint. Enquiry into the num-
ber of prescribed medication is important but not done
in this study as this is not the primary objective. It is
acknowledged that a comparison of rates of CAM use
among DM patients across different studies is limited
due to the differences in the definitions and inclusions/
exclusions of CAM therapies in each study. However,
these will not affect our findings in any way.Conclusions
This study showed that the prevalence of CAM con-
sumption/use was higher among DM patients. The high
consumption/use of CAM should prompt clinicians to
further explore this topic, particularly among DM patients
who are Muslim. In addition, future studies are
recommended to conduct a randomization trial that ana-
lyzes these herbs particularly bitter gourd, Misai Kuching,
garlic, and sabah snake grass – in reducing blood sugar
levels in local settings.Abbreviations
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